Literature DB >> 2460553

Modulation of human basophil histamine release by hemopoietic growth factors.

K Hirai1, Y Morita, Y Misaki, K Ohta, T Takaishi, S Suzuki, K Motoyoshi, T Miyamoto.   

Abstract

To determine what kinds of CSF modulate human basophil function, recombinant or purified hemopoietic growth factors were tested for the effect on histamine release from basophils. Both granulocyte (G)-macrophage (M) CSF and IL-3 markedly enhanced histamine release upon stimulation with anti-IgE in a dose-dependent manner (maximal enhancement 25.5% by GM-CSF and 30.8% by IL-3 as expressed as percent increase against total cellular histamine content), whereas G-CSF, M-CSF, and IL-4 had no effect. Enhancing action of these factors was still observed in the highly enriched basophil population, suggesting that this action was not via contaminating cells. Enhancement of histamine release by both factors was not necessarily IgE mediated, because they also amplified histamine release upon stimulation with FMLP and ionophore A23187. The enhancement by both factors was temperature dependent, and took place rapidly and reached plateau levels in 15 min. GM-CSF and IL-3 achieved the similar plateau level of augmentation and no additive effects were observed between them. This finding suggests that they enhance histamine release by sharing the same pathway in the release reaction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460553

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Seasonal increase of spontaneous histamine release in washed leucocytes from rhinitis patients sensitive to grass pollen.

Authors:  A Weyer; M T Guinnepain; J P Sutra; A Borgnon; N Herpin-Richard; M R Ickovic; J Meaume; M Raffard; F Tekaia
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

2.  Potentiation of histamine release from human leucocytes by PAF.

Authors:  R Louis; T Bury; J L Corhay; M F Radermecker
Journal:  Agents Actions       Date:  1994-03

3.  Increased numbers of circulating basophils with decreased releasability after administration of rhG-CSF to allergic patients.

Authors:  M Pedersen; K S Kristensen; P Clementsen; O T Olsen; P S Skov; H Permin; S Norn
Journal:  Agents Actions       Date:  1994-06

4.  Regulation of human basophil activation; the role of Na+ and Ca2+ in IL-3-induced potentiation of IgE-mediated histamine release from human basophils.

Authors:  F Beauvais; K Echasserieau; C Burtin; J Benveniste
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

5.  The tolerability of continuous intravenous infusion of interleukin-3 after DHAP chemotherapy in patients with relapsed malignant lymphoma. A phase-I study.

Authors:  J M Raemaekers; G W van Imhoff; L F Verdonck; J A Hessels; W E Fibbe
Journal:  Ann Hematol       Date:  1993-10       Impact factor: 3.673

6.  Studies on the association between immunoglobulin E autoreactivity and immunoglobulin E-dependent histamine-releasing factors.

Authors:  Ilona Kleine Budde; Pleuni G de Heer; Susanne Natter; Vera Mahler; Jaring S van der Zee; Rudolf Valenta; Rob C Aalberse
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

7.  Interleukin 3 activates human blood basophils via high-affinity binding sites.

Authors:  P Valent; J Besemer; M Muhm; O Majdic; K Lechner; P Bettelheim
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

8.  Differential response of human basophils and mast cells to recombinant chemokines.

Authors:  W Füreder; H Agis; H Semper; F Keil; U Maier; M R Müller; K Czerwenka; H Höfler; K Lechner; P Valent
Journal:  Ann Hematol       Date:  1995-05       Impact factor: 3.673

Review 9.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

10.  Interactions of IFN-gamma with IL-3 and IL-4 in the regulation of serotonin and arachidonate release from mouse peritoneal mast cells.

Authors:  M R Holliday; E M Banks; R J Dearman; I Kimber; J W Coleman
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.